10x Genomics Inc (TXG)

10x Genomics (TXG) Stock Price & Analysis


TXG Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$23.81 - $58.30
Previous Close$55.19
Average Volume (3M)900.42K
Market Cap
Enterprise Value$6.07B
Total Cash (Recent Filing)$420.79M
Total Debt (Recent Filing)$102.04M
Price to Earnings (P/E)-36.2
Aug 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding116,192,123
10 Day Avg. Volume1,034,969
30 Day Avg. Volume900,425
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)8.19
Price to Sales (P/S)37.73
Price to Cash Flow (P/CF)-384.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.32
Enterprise Value/Gross Profit15.33
Enterprise Value/Ebitda-42.62
Price Target Upside17.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was 10x Genomics Inc’s price range in the past 12 months?
10x Genomics Inc lowest stock price was $23.81 and its highest was $58.30 in the past 12 months.
    What is 10x Genomics Inc’s market cap?
    Currently, no data Available
    When is 10x Genomics Inc’s upcoming earnings report date?
    10x Genomics Inc’s upcoming earnings report date is Aug 02, 2023 which is in 56 days.
      How were 10x Genomics Inc’s earnings last quarter?
      10x Genomics Inc released its earnings results on May 03, 2023. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.375 by -$0.065.
        Is 10x Genomics Inc overvalued?
        According to Wall Street analysts 10x Genomics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does 10x Genomics Inc pay dividends?
          10x Genomics Inc does not currently pay dividends.
          What is 10x Genomics Inc’s EPS estimate?
          10x Genomics Inc’s EPS estimate is -$0.4.
            How many shares outstanding does 10x Genomics Inc have?
            10x Genomics Inc has 98,124,870 shares outstanding.
              What happened to 10x Genomics Inc’s price movement after its last earnings report?
              10x Genomics Inc reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.375. Following the earnings report the stock price went up 1.296%.
                Which hedge fund is a major shareholder of 10x Genomics Inc?
                Among the largest hedge funds holding 10x Genomics Inc’s share is ARK Investment Management LLC. It holds 10x Genomics Inc’s shares valued at 232M.


                  10x Genomics Stock Smart Score

                  The 10x Genomics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  10x Genomics Inc

                  10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.


                  Top 5 ETFs holding TXG

                  Market Value
                  Smart Score
                  ARK Genomic Revolution ETF
                  iShares Biotechnology ETF
                  iShares Russell Mid-Cap Growth ETF
                  iShares Russell 1000 Growth ETF
                  Vanguard Health Care ETF
                  Up to five ETFs with an Outperform Smart Score that hold TXG. The ETFs are listed according to market value of TXG within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Medpace Holdings

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis